HIPPOCRATES ( B.C.)

Similar documents
Cystatin C Den svenske erfaringen.

Cystatin C (serum, plasma, urine)

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.

International Journal of Pharma and Bio Sciences IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS?

Laboratory and Measurement Issues. Greg Miller, PhD Virginia Commonwealth University Richmond, VA

Acute renal failure Definition and detection

Case Studies: Renal and Urologic Impairments Workshop

Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

Improved estimation of glomerular filtration rate (GFR) by comparison of egfr cystatin C. and egfr creatinine

Quantitative protein estimation of Urine

NGAL, a new markers for acute kidney injury

E.Ritz Heidelberg (Germany)

Introduction to Clinical Diagnosis Nephrology

9. GFR - WHERE ARE WE NOW?

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Urinary biomarkers in acute kidney injury. Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

Quantitative estimation of protein in urine

RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

AUTOMATIC REPORTING OF CREATININE-BASED ESTIMATED GLOMERULAR FILTRATION RATE IN CHILDREN: IS THIS FEASIBLE?

Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary -trace protein

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Low molecular mass proteins as markers for renal function and dialysis efficiency

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation

Introduction to the kidney: regulation of sodium & glucose. Dr Nick Ashton Senior Lecturer in Renal Physiology Faculty of Biology, Medicine & Health

REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

SPRINT: Consequences for CKD patients

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

CYSTATIN C. An Improved Way To Screen For Chronic Kidney Disease INNOVATIONS IN CLINICAL DIAGNOSTICS

Biomarkers for optimal management of heart failure. Cardiorenal syndrome. Veli-Pekka Harjola Helsinki University Central Hospital Helsinki, Finland

Renal function vs chemotherapy dosing

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

CURICULUM VITAE. Riwayat Pendidikan : Dokter FK UNDIP 1981 Sp.Patologi Klinik 1997 Konsultan Sp2 Patologi Klinik 2007 Doktor 2015

Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology. Biomarkers of Renal Injury and Dysfunction

Assessing Renal Function: What you Didn t Know You Didn t Know

AGING KIDNEY IN HIV DISEASE

Glomerular Filtration Rate Estimations and Measurements. Pierre Delanaye, MD, PhD University of Liège CHU Sart Tilman BELGIUM

Record of the Consultation on Pharmacogenomics/Biomarkers

Proteinuria. Louisiana State University

Doppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75

Pharmacogenomics/biomarker consultation

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

GFR and Drug Dosage Adaptation: Are We still in the Mist?

ORIGINAL ARTICLE Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries

Office Management of Reduced GFR Practical advice for the management of CKD

How and why to measure renal function in patients with liver disease?

Papers in Press. Published May 14, 2014 as doi: /clinchem

Multiple Myeloma Advances for clinical pathologists & histopathologists

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

Expanding Spectrum of Diseases Associated with Plasma Cell Dyscrasias

Early Identification of the Diabetic Nephropathy; Beyond Creatinine

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Comparison of Estimated Glomerular Filtration Rate Using Different Analytes in Chronic Kidney Disease Patients

PAEDIATRIC MANAGEMENT KDIGO. Uma Ramaswami FRCPCH, MD Royal Free London NHS Foundation Trust

Identifying and Managing Chronic Kidney Disease: A Practical Approach

A New Approach for Evaluating Renal Function and Its Practical Application

Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Professor and Director. Children s Hospital of Richmond

Biomarkers of renal diseases. By Dr. Gouse Mohiddin Shaik

Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review

Discovery & Validation of Kidney Injury Biomarkers

CKD EVIDENCE TABLES - ALL CHAPTERS

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children

Forms Revision: Myeloma Changes

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

מסקנות מיישום סטנדרטיזציה של בדיקת קראטינין : שימוש בנוסחאות לחישוב egfr

Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Improved Prediction of Decreased Creatinine Clearance by Serum Cystatin C: Use in Cancer Patients before and during Chemotherapy

Novel Kidney Injury Biomarker Detected Subclinical Renal Injury in Severely Obese Adolescents with Normal Kidney Function

Renal Function and Associated Laboratory Tests

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Page 1. Disclosures. Main Points of My Talk. Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance

Estimating GFR: From Physiology to Public Health. Outline of Presentation. Applications of GFR Estimations

REVISITING THE PHARMACOKINETICS IN PATIENTS

Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

Standardization of. S.M.Boutorabi DCLS,PhD

NGAL. Changing the diagnosis of acute kidney injury. Key abstracts

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Freelite SFLC in CKD why use a different reference range? Dr Colin Hutchison Nephrologist Hawke s Bay DHB

Keywords: albuminuria; albumin/creatinine ratio (ACR); measurements. Introduction

Evaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands

EXAM COVER SHEET. Course Code: CLS 432. Course Description: Clinical Biochemistry. Final Exam. Duration: 2 hour. 1st semester 1432/1433.

Diagnostic and prognostic value of proteinuria in chronic renal diseases

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

Novel Biomarkers in Critically Ill Patients and the Emergency Room

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

Case - Acute Renal Failure

Renal Impairment From Dettli to Guideline: What can we learn?

Transcription:

HIPPOCRATES (460-375 B.C.) APHORISMS SEVENTH SECTION XXXIV When bubbles form in the urine, it is a sign that the kidneys are affected, and that the disease will be protracted

Thomas Brian cautioned in 1655 against erroneus use of urine for diagnostic purposes in his discourse The pisse-prophet or, certain pisse-pot lectures Wherein are newly discovered the old fallacies, deceit and jugling of the pisse-pot science, used by all those (wether quacks ) who pretend knowledge of diseases, by the urine, in giving judgement of the same.

Frederik Dekkers, 1648-1720, professor of medicine in Leyden, described in 1695 in De medicamentis purgantibus heat and acid precipitation to demonstrate proteinuria

The discoverers of the first specific urine protein (1845) Henry Bence Jones William MacIntyre Thomas Watson: Dear Dr. Jones. The tube contains urine of very high specific gravity. but as it cools, assumes the consistence and apperance which you see. Heat reliquifies it. What is it?

Presently, we have a catastrophic nomenclature for describing normal and abnormal urine protein patterns: It is not only wrong, but also underpins stupidity and ignorance.

Plasma-derived proteins in normal urine Albumin IgG free protein HC (α₁-microglobulin) free κ-chains free λ-chains α₂-macroglobulin orosmucoid RBP β₂-microglobulin cystatin C α ₁-antirypsin lysozyme transferrin myoglobin

Levels of plasma-derived proteins in normal urine Albumin 1 30 mg/l IgG free protein HC (α₁-microglobulin) free κ-chains free λ-chains α₂-macroglobulin orosmucoid < 5 mg/l 2 10 mg/l 1 6 mg/l 0.5 2 mg/l < 10 mg/l < 7 ml/l

Kidney-derived proteins in normal urine Tamm-Horsfall glycoprotein = uromodulin (2 200 mg/l) N-acetyl-,D-glucosaminidase (NAG) fructose-1,6-bisphosphatase fibronectin core protein-glycosaminoglycans laminin collagens Na-D-glucose cotransporter

The concept Proteinuria Addition of the upper reference values for the plasma- and kidney-derived specific proteins in urine from healthy subjects produces a value for total protein of about 270 mg/l. Is it wise to call 270 mg protein/l No proteinuria, which we must as long as we prefer to use the term proteinuria to indicate a pathological condition?

The concept Proteinuria The urine concentration of several kidneyderived specific proteins e.g. Tamm- Horsfall glycoprotein, NAG, core proteinglycosaminoglycans, is below the lower reference value in certain pathological conditions. Such observations cannot be described within the conceptual frame of proteinuriano proteinuria

The concept of Proteinura Alternative terminology Normal urine protein pattern (Normoproteinuria) Abnormal urine protein pattern (+ specifications)

Different ways of measuring urinary protein excretion

Presently, there is no shortage of suggested Markers of Renal Diseases

Protein Markers of Renal Disease Protein Plasma/Urine Damage site Albumin Plasma Glomerulus (leakage) Albumin Urine Glomerulus (leakage) 2 -microglobulin Plasma Glomerulus (GFR) 2 -microglobulin Urine Proximal tubulus -trace protein Plasma Glomerulus (GFR) -trace protein Urine Proximal tubulus core protein- Urine Glomerulus (disintegration) glycosaminoglycans Calbindin Urine Distal tubulus Clusterin Urine Tubulus Cystatin C Plasma Glomerulus (GFR) Cystatin C Urine Proximal tubulus

Protein Markers of Renal Disease (Continued) Protein Plasma/Urine Damage site Cystein-rich protein Urine Proximal tubulus EGF Epidermal Growth Factor Urine Distal tubulus Factor D (complement system) Plasma Glomerulus (GFR) Free k- and l-chains Plasma Glomerulus (GFR) Free k- and l-chains Urine Proximal tubulus Free protein HC Plasma Glomerulus (GFR) a 1 -microglobulin Free protein HC Urine Proximal tubulus a-gst a-glutathione-s-transferase Urine Proximal tubulus p-gst p-glutathione-s-transferase Urine Distal tubulus Immunoglobulin G Urine Glomerulus (leakage) Interleukin-18 Urine Multiple

Protein Markers of Renal Disease (Continued) Protein Plasma/Urine Damage site KIM-1,Kidney injury Urine Proximal tubulus molecule-1 L-FABPLiver-type fatty acid Urine Proximal tubulus binding protein NAG N-acetyl- -glucosaminidase Urine Proximal tubulus NGAL Neutrophil gelatinase- Plasma Multiple associated lipocalin NGAL Urine Proximal tubulus Podocin Urine Glomerulus (disintegration) RBP Retinol binding protein Plasma Glomerulus (GFR) RBP Urine Proximal tubulus VEGF Vascular endothelial Urine Multiple Growth factor

Markers of Renal Diseases We need markers for GFR Glomerular damage Tubular/interstitial damage Assessment of Risk for Acute Renal Failure

Markers for Glomerular Damage Urine albumin: Selective and unselective glomerular damage and systemic endothelial dysfunction (mg/mmol creatinine) Urine IgG: Unselective (i.e. worse) glomerular damage (mg/mmol creatinine) Urine IgM: Unselective (i.e. worse) glomerular damage (mg/mmol creatinine) Urine Core protein-glycosaminoglycans: Glomerular disintegration e.g. amyloidosis (mg/mmol creatinine) Urine Podocin: Glomerular disintegration

Size selectivity proteins IgG mw 150 kda, P 10000 mg/l, U< 8mg/L α₂-macroglobulin mw 720 kda, P 2000 mg/l U? IgM mw 900 kda, P 1200 mg/l, U? SI =

Charge selectivity proteins: IgG2: uncharged IgG4: negatively charged mw 150 kda P- conc. IgG1>IgG2>IgG3>IgG4 IgG2/4 ratio =

Markers for Tubular/interstitial damage Urine free protein HC (free a 1 -microglobulin): Both reversible and non-reversible damage Urine 2 -microglobulin: Both reversible and nonreversible damage Urine free k- and l-chains: Both reversible and nonreversible damage (and, if abnormal ratio, immunodyscracies like myelomatosis and MGUS)

Protein HC, alias a 1 -microglobulin, is a Human Complex-forming protein, Heterogenous in Charge Plasma contains approximately equal molar amounts of free protein HC (28 kda) and HC-IgA-complexes (180 kda) and lower amounts of several other protein HC-complexes (HCalbumin, HC-fibrinogen etc). Urine contains virtually only free protein HC. In contrast to 2 -microglobulin, protein HC is stable in native urine, in native urine stored for one week at room temperature or for one month in the refrigerator and its high urine concentrations allows the use of rapid, cheap assays methods.

Markers for Assessment of Risk for Acute Renal Failure Most accepted/used: Plasma and urine Neutrophil Gelatinase Associated Lipocalin (NGAL) Promising, awaiting confirmation: Urine Kidney Injury Molecule-1 (KIM-1) Urine free protein HC (a 1 -microglobulin) Plasma cystatin C

Markers for GFR Plasma cystatin C Plasma creatinine Plasma -trace protein Plasma factor D (complement system) Plasma 2 -microglobulin Plasma free protein HC (Free a 1 -microglobulin) Plasma RBP (Retinol Binding Protein alias a 2 -microglobulin)

Advantages of cystatin C as a GFR-marker Demonstrates the early, potentially reversible, decrease of GFR in the creatinine-blind area Independent of diet No tubular secretion Low influence by muscle mass, gender and race (African American) Independent of age for children and adults above 1 year Demonstrates the decrease of GFR in old persons Can be used to measure the renal reserve Mirrors the diurnal GFR variation Elucidates filtration quality and life expectancy

GFR-markers for patients with muscle atrophy Non-parametric ROC plots for serum cystatin C (solid line) AUC = 0.912 and serum creatinine (dotted line) AUC = 0.507 AUC = 0.50 equals the diagnostic efficiency of tossing a coin

Disadvantages of cystatin C High doses of corticosteroids increase significantly the P-Cystatin C level (but not low doses e.g. ointments, inhalation) Hyperthyreosis moderately increases the P-Cystatin C level (and decreases the P-Creatinine level due to increased tubular secretion) The cost of analysing P-Cystatin C is higher than that of analysing P-Creatinine (prices in Lund 2013: 1.5 versus 3.5 $)

Suggestion for optimal diagnostic use of egfr Run both cystatin C and creatinine and calculate egfr (cystatin C) and egfr (creatinine) at the initial patient contact. If they agree: GFR is correct, no invasive clearance determination is required. Use mean of egfr (cystatin C) and egfr (creatinine)! If they do not agree: Try to find a biomedical explanation (low muscle mass, high dose of glucocorticoid). If an obvious explanation is found no invasive clearance determination is required. The non-affected egfr is used. If the two egfrs do not agree and no obvious explanation for the difference can be found: An invasive clearance determination is justified (iohexol clearance). Site: egfr.se

Verified Markers of Renal Diseases GFR-decrease: Plasma cystatin C Glomerular damage: Urine albumin and IgG Tubular/interstitial damage: Urine free protein HC (a 1 -microglobulin) Assessment of Risk for Acute Renal Failure: Plasma and urine NGAL

Diagnosing kidney disease 2014 A To measure relative and absolute glomerular filtration rate (GFR): Iohexolor 51 Cr-EDTA-clearance (Invasive procedures) To estimate relative glomerular filtration rate (GFR): Pt-eGFR (Cystatin C) or Pt-eGFR (Creatinine), unit: ml/min/1.73m 2 body surface area. Best estimation is the mean of Pt-eGFR (Cystatin C) and Pt-eGFR (Creatinine) Internet-tool to do it: www.egfr.se To estimate absolute GFR for dosage of drugs excreted by the kidneys; unit: ml/min: Pt-eGFR (Cystatin C) or/and Pt-eGFR (Creatinine) + weight + height using internet calculators e.g. www.egfr.se To calculate risk for end-stage renal disease (hemodialysis), myocardial infarction, hospitalization and death at reduced GFR: Pt-eGFR (Cystatin C) Unit: ml/min/1.73m 2 body surface area

Diagnosing kidney disease 2014 B To analyse glomerular damage (endothelial damage), selective proteinuria : U-Albumin, spot sample, unit: mg/mmol creatinine To analyse more severe glomerular damage (endothelial damage), unselective proteinuria : U-IgG, (U-IgM) spot sample, unit: mg/mmol creatinine To analyse tubular damage: U-Protein HC (=a 1 -microglobulin), spot sample, unit: mg/mmol creatinine To analyse Bence Jones proteinuria: Ratio U-(Total) Kappa/U-(Total) Lambda-chains, spot sample, or Immunofixation of urine for kappa-, lambda-, IgG-, IgA- and IgM-immunoreactivity or Ratio P-Free Kappa/P-Free Lambdachains

Thank you for your attention and for not caressing your smartphones too much!

Extras

PNAS 1982

THE HUMAN CYSTATIN SUPERFAMILY Family 1 Family 2 Family 3 (intracellular) (extracellular) (intravascular) cystatin A cystatin C LMW-kininogen cystatin B cystatin D HMW-kininogen cystatin E cystatin F cystatin G cystatin S cystatin SA cystatin SN

Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method is a better marker than serum creatinine for glomerular filtration rate Clin Chem 40: 1921-1926, (1994)

PubMed search April 2013 for cystatin C AND (renal OR glomerular) generated 1860 hits Google search April 2013 for cystatin C : 522000 hits

Agarose gel electrophoresis of urine from patients with tubular damage

40 Å 30 Å 5 Å

Annual numbers of deaths mycardial infarctions strokes hospitalizations 1 2 3 1.0 1.5 2.0 U-Albumin (mg/mmol creatinine) P-Cystatin C (mg/l)

Functional glomerular pore size

GFR-estimating equations Relative GFR in ml/min/1.73m 2 Creatinine-based for adults: MDRDIDMS-traceable: egfr = 175 x (creatinine/88.4) -1.154 x age -0.203 x 0.742 (if female) x 1.212 (if African American) The CKD-EPI equation is more complicated Cystatin C-based for adults and children: egfr = 85 x cystatin C -1.68

Challenge To reduce/eliminate the large number of cystatin C-based GFR estimating equations Differences in diagnostic performance (bias, P30%) between equations may be due to 1. Differences in cystatin C assays used 2. Different ways of measuring GFR (clearance of iohexol, inulin, 125 I-iothalamate, 51 Cr-EDTA, 99m Tc-DTPA, creatinine clearance etc) 3. Differences between batches of cystatin C-reagents 4. Population differences

IFCC-Cystatin C-based GFR-estimating equation for adults and children: egfr = 136 x cystatin C -1 x age -0.143-7 Based upon a population of about 4000 Caucasians (Swedish, Dutch), including about 700 children and 800 Asians (Japanese) and Seven commutable cystatin C-assays adjusted to the cystatin C international calibrator ERM-DA471/IFCC (Abbott, Dako, Gentian, Roche, Sentinel, Siemens, Alfresa) and GFR measured by renal inulin clearance and plasma iohexol clearance

Creatinine-based egfr equations MDRD : 186.3 x [S- creat ( mol/l)/88.4] -1.154 x age - 0.203 x 0.742 (if female) x 1.212 (if African American) or e10.337-1.154 x ln(creat) - 0.203 x ln(age) - 0.299 (if female) + 0.192 (if African American) Only for adults Schwartz: 0.55 x height (cm) x [P- creat ( mol/l)/88.4] -1 Only for children Counahan Barratt : 0.43 x height (cm) x [P- creat ( mol/l)/88.4] -1 Only for children Lund-Malmö : e 4.62-0.0112 x creat + 0.339 x ln(age) - 0.0124 x age - 0.226 (if female) For children and adults

Age-related GFR-predictions at a constant creatinine level of 80 micromol/l for 3 prediction equations

The P30%-value for a GFR-estimating equation is the percentage of all estimations which is between +/- 30% of measured GFR (using an invasive clearance-method). The best cystatin C- and creatinin- (+sex, age and race) based equation have P30%-values of 85-90%. Equations based upon both cystatin C- och creatinine display P30%-values of 90-95%.

Present knowledge GFR-estimating equations based upon both cystatin C and creatinine, egfr mean, display the best diagnostic performance (For example, Inker et al. N Engl J Med 2012;367:20-9) (Automatic) comparison of egfr cystatinc and egfr creatinine increases diagnostic performance further and can test the reliability of the estimation (Grubb et al. Scand J Clin Lab Invest. 2012;72:73-7)

BMI: 15

BMI: 35